Englewood Lab, Inc. (KOSDAQ:950140)

Market Cap	155.37B -37.9%
Revenue (ttm)	218.19B +18.9%
Net Income	32.43B +124.2%
EPS	1,632.15 +124.2%
Shares Out	19.87M
PE Ratio	4.79
Forward PE	n/a
Dividend	201.00 (2.57%)
Ex-Dividend Date	Dec 29, 2025

Volume	8,808
Open	7,840.00
Previous Close	7,940.00
Day's Range	7,720.00 - 8,000.00
52-Week Range	7,000.00 - 16,910.00
Beta	0.30
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 6, 2026

About Englewood Lab

Englewood Lab, Inc. engages in the research, development, manufacture, and sale of cosmetic products in the United States, Korea, Canada, China, Japan, Europe, and internationally. It offers masks, cleansers, and anti-aging skincare products, as well as face, eye, and body moisturizer; primers and foundations, BB and CC Cream, concealer, blush and illuminizers, bronzer highlighter, and lip care; and over the counter products, such as SPF/ACNE, personal hygiene, and skin protectant. The company was founded in 2004 and is headquartered in Totowa,...

• Industry: Perfumes, Cosmetics, and Other Toilet Preparations
• Founded: 2004
• Country: United States
• Stock Exchange: KOSDAQ
• Ticker Symbol: 950140

Financial Performance

In 2025, Englewood Lab's revenue was 216.79 billion, an increase of 18.97% compared to the previous year's 182.22 billion. Earnings were 24.81 billion, an increase of 26.42%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Oct 15, 2026

Data Sources Report a data error